Nova Scotia

Legal analysis

Nova Scotia's abortion regime operates against the federal backdrop of R v Morgentaler, [1988] 1 SCR 30 (criminal provisions unconstitutional) and the 2019 repeal of Criminal Code ss. 287-288 by Bill C-75. The province's own attempt to restrict abortion — the Medical Services Act, which banned abortions outside hospitals — was struck down as ultra vires criminal law in R v Morgentaler, [1993] 1 SCR 462. Today, abortion is an insured service under the Health Services and Insurance Act, RSNS 1989, c 197, and the MSI Physician's Manual tariff codes (including code 03.03V for medical abortion at $117.80). The Protecting Access to Reproductive Health Care Act, SNS 2020, c 5, establishes automatic 50-metre safe-access zones around facilities providing abortion, with potential extensions to 150 metres. The College of Physicians and Surgeons of Nova Scotia adopted Professional Standards Regarding Conscientious Objection (May 24, 2024) requiring effective referral. The Midwifery Regulatory Council of Nova Scotia authorized midwife prescribing of Mifegymiso under delegation effective November 19, 2024. Nurse practitioners have been able to prescribe since December 2017. The key access limitation is geographical: four hospital sites serve a province with significant rural and remote populations, and service-policy gestational limits cap most local care at roughly 15-16 weeks.

Legal analysis

The division of powers under the Constitution Act, 1867 assigns criminal law exclusively to Parliament (s. 91(27)), while provinces control hospitals (s. 92(7)), property and civil rights (s. 92(13)), and matters of a merely local or private nature (s. 92(16)). R v Morgentaler, [1993] 1 SCR 462 confirmed that provincial legislation whose pith and substance is abortion regulation is ultra vires as criminal law. Nova Scotia's Medical Services Act, which prohibited abortion outside hospitals, was struck down on that basis. The province's valid role is therefore ancillary: it determines whether abortion is an insured service under the Health Services and Insurance Act; it regulates physicians through the CPSNS, nurses and midwives through the Nova Scotia Nursing and Midwifery Regulator, and pharmacists through the Nova Scotia College of Pharmacists; it funds hospitals through Nova Scotia Health; and it may enact safe-access-zone legislation (as it did in 2020) because protecting access to health services is a valid provincial concern under s. 92. The Canada Health Act, RSC 1985, c C-6, also operates as a federal spending-power lever, requiring provinces to insure 'medically necessary' hospital and physician services to receive full Canada Health Transfer payments, but that federal statute does not itself criminalize or directly regulate abortion.

Legal analysis

The operative legal framework includes: (1) the Health Services and Insurance Act, RSNS 1989, c 197, and MSI Regulations, under which abortion is an insured physician service, billable under tariff codes in the MSI Physician's Manual; (2) the Protecting Access to Reproductive Health Care Act, SNS 2020, c 5, establishing automatic 50-metre access zones around facilities, extendable to 150 metres, and discretionary zones of up to 160 metres around residences and 20 metres around physicians' offices; (3) the CPSNS Professional Standards Regarding Conscientious Objection (May 2024), which mandate effective referral; (4) the Midwifery Regulatory Council policy (November 2024) authorizing midwives to prescribe Mifegymiso under physician delegation; (5) the CRNNS decision (December 2017) enabling nurse practitioners to prescribe Mifegymiso. Federally, Criminal Code ss. 287-288 were repealed by Bill C-75 (SC 2019, c 25, in force September 19, 2019), confirming that abortion attracts no criminal sanction. The Canada Health Act requires provinces to insure medically necessary services, and Health Canada's 1995 policy interpretation letter confirmed that clinic abortions must be funded. Nova Scotia complies — unlike New Brunswick historically — by funding both hospital and clinic-based abortions.

Legal analysis

Under the Health Services and Insurance Act, RSNS 1989, c 197, s 8(2), all residents are insured on uniform terms for insured services. The MSI Regulations and MSI Physician's Manual list abortion among insured physician services. Tariff code 03.03V (Medical Abortion/Termination of Early Pregnancy, 45.7 units, $117.80) was introduced via an MSI Physician's Bulletin in May 2018. Mifegymiso was added to the provincial drug formulary for universal coverage effective November 1, 2017, making Nova Scotia among the early provinces to provide universal, no-cost access regardless of private insurance status. The Canada Health Act, RSC 1985, c C-6, requires that medically necessary physician and hospital services be fully insured; Health Canada's 1995 policy interpretation letter clarified that this includes clinic-based abortion. Nova Scotia has not been the subject of Canada Health Act enforcement action for abortion funding.

Legal analysis

Nova Scotia's history on this point is significant: the province's Medical Services Act, which prohibited abortion outside hospitals, was struck down as ultra vires in R v Morgentaler, [1993] 1 SCR 462. After that decision, Dr. Morgentaler opened a free-standing clinic in Halifax, which operated for some years. Today, however, all procedural abortion services have been consolidated into hospital-based clinics — primarily the ROSE Clinic at the Victoria General site of the QEII Health Sciences Centre. These are publicly funded under the Health Services and Insurance Act. Unlike New Brunswick's former Regulation 84-20 (which restricted funding to hospital abortions approved by two physicians), Nova Scotia does not maintain any regulatory distinction between hospital and clinic abortions for funding purposes. The Canada Health Act's 1995 policy interpretation letter requiring provinces to fund medically necessary clinic procedures is thus satisfied in Nova Scotia.

Legal analysis

The Interprovincial Health Insurance Agreements Coordinating Committee administers reciprocal billing agreements among provinces (excluding Quebec, which participates only in hospital agreements). Before June 2015, 'therapeutic abortion' appeared on the list of services excluded from reciprocal billing, alongside cosmetic surgery, sex-reassignment surgery, and in-vitro fertilization. In June 2015, the Committee agreed unanimously to remove abortion from the exclusion list. This required consensus from all provinces and territories; New Brunswick had been the primary obstacle. The removal means that under the portability criterion of the Canada Health Act, a Nova Scotia resident can receive an insured abortion in another province without paying point-of-service fees. The host province bills MSI directly at host-province rates.

Legal analysis

The Out of Province Travel and Accommodation Cost Assistance Program operates under the authority of the Health Services and Insurance Act and is administered by the Nova Scotia Department of Health and Wellness. Written pre-approval from the MSI Medical Consultant is mandatory before travel (Form DHW_HC_013). Eligible costs include transportation, accommodation, and meals for the patient and one travel companion if medically necessary. The 500-km one-way threshold and the requirement that the service not be available in-province are significant limitations. For abortion, this means the program is effectively limited to later-gestation cases beyond the local service-policy cutoff (~16 weeks), for which patients are typically referred to clinics in Ontario, Quebec, or the United States. The program does not assist with intra-provincial travel (e.g., from Yarmouth to Halifax), which is the more common access barrier.

Legal analysis

Abortion services are delivered through Nova Scotia Health, the single provincial health authority created by the Health Authorities Act, SNS 2014, c 32. The ROSE Clinic is the designated provincial referral centre. The centralized self-referral line (1-833-352-0719), operational since February 5, 2018, replaced the former physician-referral requirement that had made Nova Scotia an outlier among provinces. The line connects patients to the nearest provider offering the appropriate service. Action Canada's directory lists approximately 2 points of service per 201,725 women of reproductive age, among the lowest ratios in Canada, reflecting the concentration of surgical services. Mifegymiso prescribing is integrated into general primary care, with no requirement that the prescriber be affiliated with a designated clinic.

Legal analysis

No statute or regulation in Nova Scotia imposes a gestational-age restriction on abortion. The 16-week figure is a service-policy limit reflecting the clinical capacity, training, and equipment available at the ROSE Clinic and referring hospitals. Action Canada and the Abortion Access Tracker report that surgical abortion is available to about 15-16 weeks in Nova Scotia. Health Canada's on-label authorization for Mifegymiso specifies 63 days (9 weeks), but off-label prescribing beyond that is lawful and within the standard of care, as recognized by the Society of Obstetricians and Gynaecologists of Canada. Nova Scotia Health's patient-education pamphlet for procedural abortion states: 'You may be able to have a procedural abortion at the ROSE Clinic depending on how long you have been pregnant. If you are not eligible for a procedural abortion at the ROSE Clinic, we can help to connect you with care elsewhere.' The legal basis for post-16-week referrals is the Canada Health Act's portability provision and the provincial out-of-province coverage framework.

Legal analysis

Procedural abortion is performed by licensed physicians under the Medical Act, RSNS 1989, c 283, within the scope of practice regulated by the College of Physicians and Surgeons of Nova Scotia. It is an insured physician service under the Health Services and Insurance Act, billable under MSI tariff codes. The ROSE Clinic operates as a hospital outpatient department of the QEII Health Sciences Centre, governed by Nova Scotia Health policies. There are no free-standing procedural-abortion clinics in the province. Vacuum aspiration is the standard method for first-trimester procedural abortion. The NSHA 'Access to Abortions in Nova Scotia' policy and procedure manual governs clinical protocols. Patient education materials specify that the procedure does not use general anesthesia.

Legal analysis

Mifegymiso (DIN 02484937) was approved by Health Canada on July 29, 2015, under the Food and Drugs Act. Health Canada progressively relaxed prescribing restrictions: physician-only prescribing was expanded to 'health professionals' generally; mandatory physician training was removed in May 2017; the gestational limit was set at 63 days. In Nova Scotia, universal cost coverage began November 1, 2017, through the provincial Pharmacare program. Nurse practitioners have been authorized to prescribe since December 2017 (CRNNS bulletin). The Midwifery Regulatory Council of Nova Scotia adopted a policy on November 19, 2024, authorizing registered midwives to prescribe, order, and administer Mifegymiso under delegation of a physician, subject to completing an approved training course. Pharmacist dispensing is governed by the Nova Scotia College of Pharmacists. The MSI billing code 03.03V ($117.80) was introduced May 23, 2018, for medical abortion. The provincial self-referral line connects patients to Mifegymiso prescribers. VirtualCareNS and telehealth services are available for remote prescribing.

Legal analysis

Criminal Code ss. 287-288, which previously criminalized procuring miscarriage, were struck down as unconstitutional in R v Morgentaler, [1988] 1 SCR 30, and formally repealed by Bill C-75 (SC 2019, c 25). Section 223(1) confirms the born-alive rule: 'A child becomes a human being … when it has completely proceeded, in a living state, from the body of its mother.' No Canadian criminal provision targets self-managed abortion by the pregnant person. At the regulatory level, Health Canada's Food and Drugs Act and regulations govern the importation of prescription drugs; importing Mifegymiso from abroad without a prescription could technically violate the Food and Drug Regulations. The Nova Scotia Pharmacy Act and regulations, enforced by the Nova Scotia College of Pharmacists, regulate drug dispensing within the province but do not address personal importation. In practice, no Nova Scotian has been prosecuted for self-managing an abortion. Any person presenting with complications receives the same medical care regardless of how the abortion was initiated; CPSNS standards require physicians to provide care in emergent situations notwithstanding conscience objections.

Legal analysis

Physicians are licensed under the Medical Act, RSNS 1989, c 283, and regulated by CPSNS. Nurse practitioners are licensed under the Regulated Health Professions Act and registered with the Nova Scotia College of Nursing (now part of the Nova Scotia Nursing and Midwifery Regulator); the CRNNS issued a bulletin in December 2017 confirming NPs' authority to prescribe Mifegymiso. Midwives are regulated by the Midwifery Regulatory Council of Nova Scotia (now part of NSNMR) under the Midwifery Act; the MRCNS policy of November 19, 2024, authorizes prescribing, ordering, and administering Mifegymiso under physician delegation, requiring completion of an approved training course (National Abortion training for primary health providers, or UBC CPD course, or equivalent). Pharmacists are regulated by the Nova Scotia College of Pharmacists under the Pharmacy Act; the NSCP has produced guidelines supporting pharmacist dispensing of Mifegymiso. The Health Canada approval of Mifegymiso originally restricted prescribing to physicians, but Health Canada subsequently relaxed this to 'health professionals' consistent with provincial scope-of-practice rules.

Legal analysis

The CPSNS Professional Standards Regarding Conscientious Objection, approved May 24, 2024, apply to all situations including reproductive care. Standard 4: 'When a physician is unable or unwilling to provide a legally available surgical or medical treatment for reasons of conscience, the physician must make an effective referral.' An 'Effective Referral' is defined as 'a referral made in good faith to a non-objecting, available, and accessible physician, health-care professional, or agency or service that oversees the delivery of the care being sought.' Standard 2 requires disclosure of all treatment options; Standard 3 prohibits promoting personal moral or religious beliefs to patients. Standard 6 requires continuing care until the referral is complete. Standard 7 mandates care in emergencies notwithstanding conscience. The Ontario Court of Appeal in Christian Medical and Dental Society of Canada v College of Physicians and Surgeons of Ontario, 2019 ONCA 393, upheld substantially identical effective-referral requirements as a reasonable limit on s. 2(a) Charter rights under s. 1, finding the public interest in equitable access to healthcare justified the limit. For nurses, the CNA Code of Ethics for Registered Nurses (2017 edition, adopted by the Nova Scotia College of Nursing / NSNMR) includes Appendix B guidance on conscientious objection, emphasizing the duty to arrange alternative care. The Nova Scotia College of Pharmacists' Code of Ethics and standards similarly require continuity of care in conscientious objection situations.

Legal analysis

The Health Authorities Act, SNS 2014, c 32, consolidated Nova Scotia's nine district health authorities into a single Nova Scotia Health authority, effective April 1, 2015. All public hospitals fall under this secular authority, governed by a board appointed by the provincial government. The IWK Health Centre in Halifax is a separate, specialized women's and children's hospital — also secular and publicly funded. Nova Scotia does not have the religiously affiliated hospital system found in provinces like Ontario (where Catholic hospitals operate under the Public Hospitals Act with denominational privileges). There is no provincial statute or regulation permitting a publicly funded institution to refuse abortion on religious grounds. The absence of institutional objection removes a barrier that exists in several other Canadian provinces.

Legal analysis

The Protecting Access to Reproductive Health Care Act, SNS 2020, c 5 (Bill 242), received royal assent on March 10, 2020, after unanimous all-party support. Section 7 establishes automatic access zones for every facility specified in regulations, extending 50 metres from the parcel boundaries (subject to exceptions for private property not owned or occupied by the facility). The Governor in Council may, by regulation, extend the zone to up to 150 metres (s. 16(1)(d)). Section 8 authorizes, by regulation, access zones of up to 160 metres around physicians' or service providers' residences. Section 9 authorizes zones of up to 20 metres around physicians' offices. The Act defines 'facility' broadly to include hospitals, clinics, physicians' offices, pharmacies, and other prescribed premises (s. 2(e)). Prohibited activities (s. 3) include: interference (advising against abortion), protest, besetting, repeated observation, requesting that someone refrain from accessing or providing abortion, physical impediment, and intimidation. Section 4 prohibits recording of patients, physicians, or service providers without consent. Section 6 prohibits harassment outside access zones for the purpose of dissuading provision of services. Offences are prosecuted summarily (s. 10). The Act creates a civil cause of action for damages (s. 12) and permits any person, including the Attorney General, to seek an injunction (s. 13). The legislation was modeled on BC's Access to Abortion Services Act, RSBC 1996, c 1, which survived Charter challenge in R v Spratt, 2008 BCCA 340. Nova Scotia's Act goes further by including pharmacies and expanding the prohibited-activity list. No constitutional challenge has been filed against Nova Scotia's Act.

Legal analysis

Nova Scotia has not enacted a statutory age of medical consent. The common-law mature-minor doctrine, recognized by the Supreme Court of Canada in AC v Manitoba (Director of Child and Family Services), 2009 SCC 30, [2009] 2 SCR 181, applies: a minor who demonstrates sufficient intelligence and understanding to appreciate the nature and consequences of a proposed treatment may consent. The age of majority in Nova Scotia is 19 (Age of Majority Act, RSNS 1989, c 4), but this does not create a medical-consent threshold. The Nova Scotia Health 'Access to Abortions' policy does not impose parental-involvement requirements. The self-referral line does not ask for age verification or parental consent. Providers apply the mature-minor assessment as they would for any medical treatment. There is no statutory parental-consent or notification requirement specific to abortion.

Legal analysis

The Personal Health Information Act, SNS 2010, c 41 (PHIA), governs the collection, use, and disclosure of personal health information by custodians (including hospitals, physicians, and pharmacies) in Nova Scotia. Under PHIA, if a minor has the capacity to consent to treatment, they also have the capacity to exercise the rights of an 'individual' under the Act, including the right to consent to or refuse disclosure of their personal health information. IWK/NSHA policy confirms that a '14 year old with capacity has the legal right to provide consent (or not) to their parents/legal guardian having access to the patient's PHI.' While this specific policy reference mentions age 14 as a presumptive-capacity threshold, it is not a statutory rule; the common-law mature-minor test governs.

Legal analysis

The born-alive rule is codified in Criminal Code s. 223(1) and applies by analogy in civil law. At common law, a fetus has no legal personality and cannot be the subject of a tort action unless born alive. The Nova Scotia Fatal Injuries Act, RSNS 1989, c 163, creates a statutory cause of action for dependants when a person's death is caused by wrongful act, but it defines claims by reference to the death of a 'person' and does not extend to fetuses. In Dobson (Litigation Guardian of) v Dobson, [1999] 2 SCR 753, the Supreme Court of Canada held that public policy precludes imposing a duty of care on a pregnant woman toward her unborn child, and that the born-alive rule does not support maternal liability for prenatal negligence. Tremblay v Daigle, [1989] 2 SCR 530, confirmed that a fetus has no legal personality and that no one — including the father — has standing to enjoin an abortion. Third-party claims for prenatal injury to a child subsequently born alive are permitted under the common law (Montreal Tramways v Léveillé, [1933] SCR 456).

Legal analysis

In Tremblay v Daigle, [1989] 2 SCR 530, the Supreme Court of Canada held unanimously that a fetus has no legal personality under Quebec civil law or the common law, that the father had no legal interest entitling him to enjoin the pregnant person from obtaining an abortion, and that the Quebec Charter of Human Rights and Freedoms does not extend to the unborn. This precedent is binding across all provinces. No Nova Scotia statute or regulation purports to grant a father, spouse, or other third party any right to prevent or delay an abortion. The Protecting Access to Reproductive Health Care Act, SNS 2020, c 5, reinforces the autonomy of the pregnant person by protecting access from interference. Any common-law claim by a father in tort (e.g., for emotional distress) arising from an abortion would face insurmountable doctrinal barriers given the Supreme Court's holdings.

Legal analysis

Winnipeg Child and Family Services (Northwest Area) v G (DF), [1997] 3 SCR 925, held that the parens patriae jurisdiction of the courts does not extend to the protection of unborn children because the fetus has no legal personality, and that extending tort law to permit detention of a pregnant person would require a legislative choice that the courts cannot make. The Supreme Court specifically declined to extend the common law to authorize detention and treatment of a pregnant substance-using woman. Nova Scotia's Children and Family Services Act, SNS 1990, c 5, applies to children under the age of 16 (or under 19 in limited circumstances) and does not contain any provision addressing fetal protection or authorizing pre-birth intervention. The Act defines 'child' by reference to a person who has been born. Canadian law does not recognise unborn children as legal persons, and therefore Nova Scotia child-welfare authorities cannot obtain pre-birth protection orders.

Legal analysis

VirtualCareNS is a publicly funded service operated by Nova Scotia Health, providing virtual primary care to residents on the Need a Family Practice Registry and others without a primary care provider. CPSNS guidance on virtual care permits physicians to prescribe via telehealth provided they meet the standard of care. There is no legal barrier to telehealth prescribing of Mifegymiso, and Health Canada has not restricted remote prescribing. The MSI billing framework includes virtual-care billing codes. For out-of-province prescribers serving Nova Scotia residents, the licensure requirements of the Medical Act would apply — a physician licensed in another Canadian province may need Nova Scotia licensure or fall under the Atlantic Registry, which facilitates cross-jurisdictional practice among Atlantic provinces. The Patient Access to Care Act, SNS 2023, c 3, further facilitates out-of-province health professionals providing services to Nova Scotia residents.

Legal analysis

For Nova Scotia residents seeking care out of province, the MSI Out-of-Province coverage provisions apply: medically necessary services not available in Nova Scotia are insured if pre-approved. For out-of-country referrals (e.g., to the United States for later-gestation abortions), the MSI Medical Consultant must confirm the service is not available in Canada. Coverage is at Nova Scotia rates, which may not cover the full cost of US services. For non-residents accessing care in Nova Scotia, the Interprovincial Reciprocal Payment Agreement for Physician Services applies: residents of participating provinces (all except Quebec) presenting a valid health card can access insured services without point-of-service payment, and Nova Scotia Health bills the home province. Since the June 2015 removal of abortion from the reciprocal billing exclusion list, abortion is treated like any other medically necessary insured service for reciprocal billing. Quebec residents must pay upfront and seek reimbursement from RAMQ.